Stability & Regulatory Support
January 24, 2020
ICH Stability program to support semipermeable conditions. Regulatory team supports project throughout regulatory lifecycle.
Analytical & Microbiology Support
January 24, 2020
Dedicated multidisciplinary team to support all aspects of development from method development, method validation, sterility & bioburden along with our robust microbiology lab.
Process Development & Technology Transfer
January 24, 2020
Development engineering teams lead all aspects of product development/transfers from the clinical study stage and manage projects throughout the development lifecycle, process validation & commercial launch.
Recent Posts
- Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.
- Ritedose Launches Two New Single-Dose Syringe Products Amid National Drug Shortage: Bupivacaine Hydrocholoride 0.25% (2.5 mg/mL) and Bupivacaine Hydrocholoride 0.5% (5 mg/mL)
- Ritedose Launches Critical Single-Dose Syringe Product Amid National Drug Shortage: Lidocaine Hydrochloride 1% 100 mg/10 mL
-
Ritedose Reaches Milestone with Asset Purchase
Becomes largest generic drug maker of its kind - Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals: Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL)
Archives
Categories
Recent News
Post Categories
- In the News (12)
- Press Releases (10)
- Uncategorized (11)
Recent Comments